Physician profile
Robert S Katz
NPI 1790875797
$1,194.20
in general payments reported to CMS, 2019-2025
6 companies · $50.32 in 2025
The $50.32 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.32 · 2020: $31.30 · 2021: $55.85 · 2022: $815 · 2023: $95.63 · 2024: $93.14 · 2025: $50.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $164 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.10 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $700.00 | 2022 | |
| Janssen Biotech, INC. | $221.43 | 2022-2024 | Tremfya |
| Ucb, INC. | $113.48 | 2019-2023 | Cimzia |
| Amgen INC. | $70.90 | 2021-2025 | Otezla |
| Novo Nordisk INC | $46.26 | 2023-2025 | Wegovy, Ozempic |
| Glaxosmithkline, LLC. | $42.13 | 2021-2023 | Benlysta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.